UnknownPhase 3NCT03405974

Aspirin in the Prevention of Collapse in Osteonecrosis of the Hip

Studying Osteonecrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Principal Investigator
Chantal Séguin, MD
McGill University Health Centre/Research Institute of the McGill University Health Centre
Intervention
Aspirin(drug)
Enrollment
114 enrolled
Eligibility
18-60 years · All sexes
Timeline
20172021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03405974 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis

← Back to all trials